2007
DOI: 10.1007/s00415-006-0439-x
|View full text |Cite
|
Sign up to set email alerts
|

Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(32 citation statements)
references
References 8 publications
(6 reference statements)
1
31
0
Order By: Relevance
“…†Calculated using 1400 g as the average weight of the human brain in order to be consistent with calculations from Arlt et al 17 …”
Section: Discussion and Review Of The Literaturementioning
confidence: 97%
See 2 more Smart Citations
“…†Calculated using 1400 g as the average weight of the human brain in order to be consistent with calculations from Arlt et al 17 …”
Section: Discussion and Review Of The Literaturementioning
confidence: 97%
“…Calculated using 1400 g as the average weight of the human brain in order to be consistent with calculations from Arlt et al 17 †Intrathecal administration was unintentional.‡Unintentional intrathecal administration was due to drug error.GBCA, gadolinium-based contrast agent.…”
Section: Discussion and Review Of The Literaturementioning
confidence: 97%
See 1 more Smart Citation
“…In two published cases, the high-dose administration of GD produced a fluctuating level of consciousness and neurological deficits (1, 10). In one case, the total gadolinium dose administered intravenously over 7 days was 60-80 mL (1).…”
Section: Discussionmentioning
confidence: 99%
“…[34][35][36] In 2 previous reports, the behavioral and neurologic alterations were observed only after the intraventricular injection of relatively high doses of Gd; no such behavioral or morphologic changes were observed in the same studies when the total dose was limited to Ͻ3.3 mol/g brain in 15 L. 37,38 However, several recent studies reported intrathecal Gd-induced encephalopathy in humans after the accidental intrathecal injection of a high dose of Gd. 39,40 In these cases, the patients developed severe neurologic symptoms, such as dysarthria, blurred vision, nystagmus, ataxia, and somnolence, followed by behavioral disturbances and psychotic symptoms.…”
Section: 12mentioning
confidence: 99%